Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPMT | P51580 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 6/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | P2RY14 | Q15391 | 2/20 | 0.40 |
| ▸ | LCK | P06239 | 1/20 | 0.40 |
| ▸ | FABP1 | P07148 | 1/20 | 0.40 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6232755 | 0.90 | MEN1 (0.49) | MEN1KMT2APOLBCA12CA1 | |
| SCHEMBL2890076 | 0.90 | PKM (0.47) | MEN1KMT2APOLBCA12CA1 | |
| SCHEMBL26162759 | 0.88 | CYP17A1 (0.42) | MEN1KMT2ACA12CA1CA9 | |
| SCHEMBL7477384 | 0.87 | CA12 (0.48) | MEN1KMT2ACA12CA1CA9 | |
| SCHEMBL31568470 | 0.86 | KDM4E (0.55) | MEN1KMT2ACA12CA1CA9 | |
| SCHEMBL22469882 | 0.86 | KDM4E (0.55) | MEN1KMT2ACA12CA1CA9 | |
| SCHEMBL2178704 | 0.84 | CA12 (0.46) | MEN1KMT2APOLBHCAR1CA12 | |
| SCHEMBL9396335 | 0.83 | KDM4E (0.55) | MEN1KMT2APOLBMAPTL3MBTL1 | |
| SCHEMBL29032844 | 0.83 | L3MBTL1 (0.46) | MEN1KMT2AHCAR1CA12CA1 | |
| SCHEMBL4726163 | 0.83 | EPHX2 (0.42) | MEN1KMT2APOLBCA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230241257-A1 | BIOTIN-MODIFIED DIMER AND USE THEREOF | THE UNIVERSITY OF TOKYO (JP) | 2023-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230241257-A1 | BIOTIN-MODIFIED DIMER AND USE THEREOF | BTD, HLCS, BRD4 | TPMT 1559/4885MEN1 1671/4885KMT2A 2351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.